|
Delayed
NYSE
01:10:00 14/11/2025 +04
|
5-day change | 1st Jan Change | ||
| 31.61 USD | -0.37% |
|
+3.30% | +6.90% |
Investment objective
Putnam BioRevolutionTM ETF Seeks long-term capital appreciation by investing mainly in common stocks of companies of any size with a focus on those that Putnam believes offer the opportunity to capitalize on a convergence of technological developments in the life sciences sector.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 608.55USD | +0.92% | +5.04% | 7.08% | |
| 204.99USD | -0.12% | -10.51% | 6.67% | |
| 378.15USD | -0.52% | +24.56% | 5.42% | |
| 223.76USD | -0.87% | +20.04% | 5.2% | |
| 330.82USD | -2.23% | +5.62% | 4.97% | |
| 84.77USD | -1.32% | +26.96% | 4.32% | |
| 250.78USD | +0.81% | +9.68% | 4.16% | |
| 808.05USD | -0.28% | +4.48% | 4.05% | |
| 1,122.90USD | -0.09% | +4.73% | 3.56% | |
In partnership with
Description
| US7467298052 |
|---|
- Stock Market
- ETF
- SYNB ETF
Select your edition
All financial news and data tailored to specific country editions
